Ffcm LLC reduced its holdings in shares of Walgreens Boots Alliance (NASDAQ:WBA) by 17.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 31,581 shares of the pharmacy operator’s stock after selling 6,539 shares during the period. Ffcm LLC’s holdings in Walgreens Boots Alliance were worth $2,069,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of WBA. Parkside Investments LLC lifted its position in Walgreens Boots Alliance by 3.0% during the fourth quarter. Parkside Investments LLC now owns 24,806 shares of the pharmacy operator’s stock valued at $1,801,000 after buying an additional 715 shares during the period. BTIM Corp. increased its holdings in shares of Walgreens Boots Alliance by 3.5% during the fourth quarter. BTIM Corp. now owns 21,457 shares of the pharmacy operator’s stock valued at $1,558,000 after acquiring an additional 725 shares in the last quarter. Eads & Heald Investment Counsel increased its holdings in shares of Walgreens Boots Alliance by 3.6% during the fourth quarter. Eads & Heald Investment Counsel now owns 21,249 shares of the pharmacy operator’s stock valued at $1,543,000 after acquiring an additional 748 shares in the last quarter. IFM Investors Pty Ltd increased its holdings in shares of Walgreens Boots Alliance by 3.0% during the third quarter. IFM Investors Pty Ltd now owns 25,769 shares of the pharmacy operator’s stock valued at $1,990,000 after acquiring an additional 762 shares in the last quarter. Finally, 440 Investment Group LLC increased its holdings in shares of Walgreens Boots Alliance by 1.6% during the fourth quarter. 440 Investment Group LLC now owns 49,341 shares of the pharmacy operator’s stock valued at $3,583,000 after acquiring an additional 780 shares in the last quarter. Institutional investors and hedge funds own 61.52% of the company’s stock.
Walgreens Boots Alliance opened at $65.99 on Friday, Marketbeat reports. The stock has a market cap of $65.19 billion, a P/E ratio of 12.94, a P/E/G ratio of 1.07 and a beta of 1.15. Walgreens Boots Alliance has a 52 week low of $64.88 and a 52 week high of $65.72. The company has a current ratio of 0.90, a quick ratio of 0.45 and a debt-to-equity ratio of 0.44.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping the consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The firm had revenue of $33.02 billion for the quarter, compared to analyst estimates of $32.20 billion. During the same period last year, the company earned $1.36 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 12.1% compared to the same quarter last year. research analysts anticipate that Walgreens Boots Alliance will post 5.92 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, May 17th. This represents a $1.60 annualized dividend and a dividend yield of 2.42%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 31.37%.
Several research firms recently commented on WBA. Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Monday, January 22nd. Mizuho set a $87.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Wednesday, January 24th. ValuEngine cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Royal Bank of Canada set a $94.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Friday, February 16th. Finally, Bank of America started coverage on Walgreens Boots Alliance in a report on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $83.20.
In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total value of $179,372.16. Following the transaction, the director now owns 13,679 shares in the company, valued at $896,795.24. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 14.80% of the company’s stock.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.